INTRODUCTION
The movement of cholesterol from the liver into bile is a complex and poorly understood process. Bile cholesterol is entirely free cholesterol (FC) and derives in part from hepatic preformed stores and from new hepatic synthesis. We have previously shown in the rat [1, 2] that radiolabelled FC that is taken up from lipoproteins by the liver rapidly equilibrates throughout the liver with all other hepatic FC. Thus, bile preformed cholesterol has the same specific radioactivity as preformed cholesterol throughout the liver. In contrast, cholesterol that is newly synthesized in the liver has a much higher specific radioactivity in bile than in the liver [3] [4] [5] . This has led to the speculation that newly synthesized cholesterol in bile may derive from a special pool of cholesterol within the liver or, alternatively, that newly synthesized cholesterol is preferentially secreted from the liver into bile.
Attempts to identify a precursor site for newly synthesized bile cholesterol have thus far been unsuccessful, isolating from whole liver by conventional techniques intracellular organelles in which cholesterol synthesis takes place. However, it has been demonstrated that hepatic cholesterol synthesis may ordinarily only take place in a subpopulation of hepatocytes that are localized to the periportal region of the liver lobule [6, 7] . Thus it is possible that newly synthesized cholesterol may be directly secreted into bile from just a portion of the total hepatocyte mass. As a consequence, newly synthesized cholesterol in bile would have a relatively high specific radioactivity compared with newly synthesized cholesterol in the liver that is mixed with cholesterol from hepatocytes that are not synthesizing cholesterol.
It has been demonstrated [6] the number of hepatocytes that synthesize cholesterol will also increase. In the present study we have treated rats with a bileacidbinding resin to determine the effect of an increase in the n,umbr of hepatocytes that synthesize cholesterol on the relative specific radioactivity of newly synthesized cholesterol in the liver and bile. We reasoned that, if the specific radioactivity of newly synthesized cholesterol in liver more closely resembled bile as a result of increased hepatic synthesis, then the disparity in specific radioactivities between liver and bile could be attributed to the size of the hepatic site of cholesterol synthesis rather than to the preferential secretion of newly synthesized cholesterol from the liver into bile. blood and exchange back to the liver. In short-term experiments, newly synthesized cholesterol was measured in bile collected for just 5 min, from 10 to 15 min after [3H]water injection. At 15 min rats were killed by exsanguination and livers were per-fused free of blood, homogenized, and used to prepare microsomes [8] .
MATERIALS AND METHODS
Long-term experiments were performed to demonstrate that changes in the rate of secretion of newly synthesized FC in bile may depend not only on the rate of FC synthesis by the liver but also on the times (after the injection of a radiolabelled precursor) at which measurements of newly synthesized FC in bile are made. In these experiments, after injection of [3H]water, newly synthesized cholesterol was measured in bile and serum at intervals for up to 120 or 240 nin and in the liver that was obtained at the end of each experiment (half were concluded at 120 min and half concluded at 240 min). To minimize interruption of the enterohepatic circulation, the bile-duct cannula was connected to a duodenal cannula and the connection was broken to obtain bile for 5 min periods. Serum was obtained at the mid-point of each bile collection from a femoral artery cannula.
Bile, serum, whole liver, and liver microsomes were extracted for lipids [9] . FC was isolated from cholesteryl esters and other neutral lipids by h.p.l.c., as we have previously described [10] , and FC mass was determined by integration in conjunction with an internal stigmasterol standard. Bile acids were measured by an enzymic method [11] after purification on a Supelclean LC18 cartridge (Supelco, Bellefonte, PA, U.S.A.), by a previously described procedure [12] . The 3H radioactivity in FC and in bile acids was determined by liquid-scintillation counting. The absolute amount of newly synthesized FC -in bile was calculated as previously outlined [13] , by using data showing that 21 H (measured as 3H) atoms from water are incorporated into each newly synthesizxed molecule of cholesterol [14] . Serum [3H] water has been shown to be fully equilibrated with tissue water by 5 min after intravenous injection of the radioisotope [15] . In the present experiments, the specific radioactivity of 3H in serum water at 15 min (short-term experiments) and at 30 and 120 min (long-term experiments) was used as the precursor specific radioactivity to calculate newly synthesized cholesterol. (The specific radioactivities of [3H]water at 30 and 120 min in individual animals differed by less than 3 % and were averaged.) All results that were expressed in terms of specific radioactivity of newly synthesized FC (i.e. d.p.m./,umol of FC) were normalized to account for variations in the amount of [3H]water that was given to individual animals. Statistical differences between groups were determined by Student's t test for unpaired variables.
RESULTS

Newly synthesized cholesterol in bile in short-term experiments
Body weight and weight gain were not significantly different in resin-fed animals and in chow-fed controls (Table 1) . However, resin-fed animals had smaller livers than controls and significantly lower rates of biliary cholesterol and bile salt secretion than controls (Table 1 ). In this group of animals, newly synthesized cholesterol was measured in bile from 10 to 15 min after the intravenous injection of [3H]water, and in liver 15 min after the radioisotope had been injected.
The effects of resin feeding on the relative amounts of newly synthesized cholesterol in bile, whole liver and liver microsomes are shown in Figure 1 (a) and in serum and liver in Figure l( Blilary secretion of newly synthesized bile salts As a result of resin feeding and a decrease in bilt salt secretion (Table 1) , the synthesis of bile salts was significantly increased (Figure 2 ). In contrast with the secretion of newly synthesized FC in bile, the secretion of newly synthesized bile salts was 3-4-fold greater in resin-fed animals than in controls at every time period at which bile was sampled (P < 0.02-0.001).
DISCUSSION
Results demonstrate that the large difference in specific radioactivity of newly synthesized cholesterol in bile and liver can be decreased to a considerable extent by stimulating hepatic cholesterol synthesis with a bile-acid binding resin. Treatment of rats with a resin has been shown to increase the number of liver cells that synthesize cholesterol [61. We found that with resin treatment hepatic cholesterol synthesis was markedly increased, but was not accompanied by increased secretion of newly synthesized cholesterol in bile. It can thus be inferred that the specific radioactivity of newly synthesized cholesterol in bile is greater than in the liver, not because there is 'preferential' secretion of newly synthesized cholesterol in bile, but because newly synthesized cholesterol is secreted in bile from just a portion of the total hepatocyte mass. That is, although all hepatocytes may have the potential to synthesize cholesterol, only a select population of these cells will provide newly synthesized cholesterol for bile.
Our findings with regard to the secretion of newly synthesized cholesterol in bile are strikingly different from the results of others, who have found that resin treatment not only increases hepatic cholesterol synthesis but also increases the secretion of newly synthesized cholesterol in bile [4, 16] . We believe that the finding of an increase in the specific radioactivity of bile cholesterol with resin treatment does not truly reflect an increase in newly synthesized bile cholesterol and can most probably be attributed to FC exchange between the liver and blood during the course of an experiment that takes place over a relatively prolonged period. It is possible for FC exchange to confound the results of a study in the following manner: when a prolonged time (of the order of several hours) is allowed to elapse after the administration of a radioisotopic precursor of cholesterol, appreciable amounts of newly synthesized FC are transported from the liver into the blood and result in an increasing specific radioactivity of serum FC. When this radiolabelled FC exchanges back into the liver, it has the specific radioactivity of serum FC. Thus, in reality, in this type of experiment the source of newly synthesized FC in bile may be viewed as not just the newly synthesized FC that is directly derived from its site of synthesis in the liver, but also the newly synthesized FC (with a different specific radioactivity) that is derived from the serum. Our previous studies [1] suggested that because of the rapidity of serum FC exchange (with a ti of -4 min) and transport into bile, in studies of many hours duration the specific radioactivity of bile cholesterol will always closely correspond to the specific radioactivity of FC in the serum. Our present study demonstrates that, although by 4 h after administration of [3H]water the specific radioactivity of bile FC still clearly exceeded the specific radioactivity of FC in serum (cf. Figures la and lb) , the specific radioactivity of bile FC had reached a plateau, whereas the specific radioactivity of serum (and liver) FC was linearly increasing. Furthermore, the specific radioactivity of serum FC in the resin-fed group was increasing in a considerably greater rate than in controls.
In the present study, we avoided the problem of cholesterol exchange by measuring bile cholesterol specific radioactivities very early after the administration of a cholesterol precursor (10-15 min after administration of [3H]water) and before any significant increase in newly synthesized cholesterol in serum. It is possible to measure cholesterol synthesis this early after [3H]water administration, since [3H]water has been found to be fully equilibrated with the water in a variety of body tissues by 5 min after its intravenous injection [15] . We found that newly synthesized cholesterol accounted for just 7 .0 ,' of the cholesterol secreted in bile (calculated for 1 h of bile output) in both controls and resin-fed rats. We have previously reported [13] that 9.5 %, bile cholesterol was newly synthesized in studies using the isolated perfused rat liver, in a serum-free system in which exchange is negligible.
It is not possible to calculate the absolute rate of synthesis of bile salts from the incorporation of 3H atoms from water without knowing the extent to which newly synthesized and preformed cholesterol in the liver serve as substrates for bile salt synthesis (i.e. 3H labelling). However, it is clear from a comparison of bilesalt specific radioactivities (Figure 2 ) that the biliary secretion of newly synthesized bile salts in resin-fed animals.greatly exceeded that of controls at every time point and, in contrast with cholesterol, the difference in synthesis between the two groups remained relatively constant over the 4 h of study (the ratio of d.p.m./,umol of bile salt in controls to that in resin-fed. animals ranged from 0.23 to 0.30 throughout the period of study).
With immunofluorescence microscopy, it has been observed [6] that about 20 % of liver cells in untreated rats stain positive for 3-hydroxy-3-methylglutary-CoA (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol synthesis. This estimate of the percentage of liver cells that are actively synthesizing cholesterol closely corresponds to the (percentage) difference between liver and bile specific radioactivities of newly synthesized cholesterol that we observed in the control group of rats. That is, in controls the specific radioactivity of cholesterol in the liver was 20 % of the specific radioactivity of cholesterol in bile (Table 2 ). This would be expected if only 20 % of hepatocytes synthesize cholesterol for bile and the specific radioactivity of newly synthesized cholesterol in the liver is decreased by the (preformed) cholesterol in the remaining 800% of hepatocytes that are not synthesizing cholesterol.
The population of hepatocytes that ordinarily is positive for HMG-CoA reductase is sharply localized to the periportal region of the liver [6, 7] . With the induction of cholesterol synthesis by drug treatment (with a resin, a HMG-CoA reductase inhibitor, or both in combination), many more liver cells, which are widely distributed throughout the liver, stain positive for HMG-CoA reductase [6, 7] . If the assumption is made that the amount of cholesterol synthesized by each 'synthesizing' liver cell is the same, then it is possible that all of bile cholesterol originates from a subpopulation of hepatocytes that constitutes about 20 % of the total heptocyte mass. This would explain why the specific radioactivity of FC in liver is ordinarily about 200% of the specific radioactivity of FC in the bile and why, with an increase in liver cholesterol synthesis, there is no increase in the specific radioactivity of newly synthesized cholesterol in bile.
